Clinical
Clinical
IND Enabling
Phase I
Phase II
Phase III
Relapsed or Refractory Acute Myeloid Leukemia, AML, (NCT06128044)
Sponsors:
Caribou Biosciences, Inc.
Sponsors:
Caribou Biosciences, Inc.

IND Enabling
Phase I
Phase II
Phase III
Neovascular Age-related Macular Degeneration, nAMD, (NCT06031727)
Sponsors:
HuidaGene Therapeutics Co., Ltd.
Sponsors:
HuidaGene Therapeutics Co., Ltd.

IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
T-Cell Acute Lymphoblastic Leukaemia, T-ALL, (ISRCTN15323014)
Sponsors:
Great Ormond Street Hospital
Sponsors:
Great Ormond Street Hospital

IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III